UREMIC CARDIOMYOPATHY
DOI:
https://doi.org/10.37321/nefrology.2022.30-31-03Keywords:
arrhythmia, transplantation, hypertension, left ventricular hypertrophy, dialysis, chronic renal failure, QT interval.Abstract
Introduction. Chronic kidney disease (CKD) is common, affecting one in seven of Western populations. There is a well-documented graded inverse relationship between cardiovascular risk and estimated glomerular filtration rate (eGFR) that is independent of age, sex and other risk factors
Goal. To review the literature of patients with uremic cardiopathy.
Materials and methods. Review of modern and foreign literary sources; methods – description, analysis, abstracting.
Results and their discussion. The work is described in detail сhronic kidney disease, uremic сardiomyopathy, causes, pathogenesis, complications.
Conclusions. Uremic cardiopathy depends largely on non-specific and potentially reversible factors such as anemia, hypertension and over hydration. It is the association and long-term persistence of these factors that are relatively specific to uremia.
References
Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296–305.
Wang X, Shapiro JI. Evolving concepts in the pathogenesis of uremic cardiomyopathy. Nat Rev Nephrol 2019;15:159–75.
Mark PB, Johnston N, Groenning BA, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006;69:1839–45.
Edwards NC, Moody WE, Yuan M, et al. Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease. Am J Cardiol 2015;115:1311–7.
Moody WE, Edwards NC, Chue CD, et al. Arterial disease in chronic kidney disease. Heart 2013;99:365–72.
Rutherford E, Talle MA, Mangion K, et al. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping. Kidney Int 2016;90:845–52.
Graham-Brown MP, Rutherford E, Levelt E, et al. Native T1 mapping: inter-study, interobserver and inter-center reproducibility in hemodialysis patients. J Cardiovasc Magn Reson 2017;19:1–10.
Aoki J, Ikari Y, Nakajima H, et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 2005;67:333–40.
Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356:830–40.
Feher A, Sinusas AJ. Quantitative Assessment of Coronary Microvascular Function. Circulation 2017;10:1–21.
Bezante GP, Viazzi F, Leoncini G, et al. Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage. Am J Hypertens 2009;22:191–6.
Caliskan Y, Oflaz H, Demirturk M, et al. Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients. Clin Transplant 2008;22:785–93.
Bozbas H, Pirat B, Demirtas S, et al. Evaluation of coronary microvascular function in patients with end-stage renal disease, and renal allograft recipients. Atherosclerosis 2009;202:498–504.
Shah NR, Charytan DM, Murthy VL, et al. Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol 2016;27:1823–9.
Nakanishi K, Fukuda S, Shimada K, et al. Prognostic value of coronary flow reserve on long-term cardiovascular outcomes in patients with chronic kidney disease. Am J Cardiol 2013;112:928–32.
Paz Y, Morgenstern R, Weinberg R, et al. Relation of Coronary Flow Reserve to Other Findings on Positron Emission Tomography Myocardial Perfusion Imaging and Left Heart Catheterization in Patients With End-stage Renal Disease Being Evaluated for Kidney Transplant. Am J Cardiol 2017;120:1909–12.
Chade AR, Brosh D, Higano ST, et al. Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. Kidney Int 2006;69:266–71.
Ragosta M, Samady H, Isaacs RB, et al. Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J 2004;147:1017–23.
Nelson AJ, Dundon BK, Worthley SG, et al. End-stage renal failure is associated with impaired coronary microvascular function. Coron Artery Dis 2019:1.
Koivuviita N, Tertti R, Järvisalo M, et al. Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease. Nephrol Dial Transplant 2009;24:2773–9.
Charytan DM, Shelbert HR, Di Carli MF. Coronary microvascular function in early chronic kidney disease. Circ Cardiovasc Imaging 2010;3:663–71.
Charytan DM, Skali H, Shah NR, et al. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int 2018;93:501–9.
Imamura S, Hirata K, Orii M, et al. Relation of albuminuria to coronary microvascular function in patients with chronic kidney disease. Am J Cardiol 2014;113:779–85.
Niizuma S, Takiuchi S, Okada S, et al. Decreased coronary flow reserve in haemodialysis patients. Nephrol Dial Transplant 2008;23:2324–8.
Tok D, Gullu H, Erdogan D, et al. Impaired coronary flow reserve in hemodialysis patients: a transthoracic Doppler echocardiographic study. Nephron Clin Pract 2005;101:c200–c206.
Viganò SM, Turiel M, Martina V, et al. Reduced coronary flow reserve in young adults with renal transplant. Nephrol Dial Transplant 2007;22:2328–33.
Turiel M, Sitia S, Tomasoni L, et al. Subclinical impairment of coronary flow velocity reserve assessed by transthoracic echocardiography in young renal transplant recipients. Atherosclerosis 2009;204:435–9.
Akagun T, Caliskan Y, Alpay N, et al. Long-term prognostic value of coronary flow velocity reserve in renal transplant recipients. Transplant Proc 2011;43:2612–6.
Murthy VL, Naya M, Foster CR, et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging 2012;5:1025–34.
Tona F, Silvestre C, Rigato M, et al. Coronary Microvascular Dysfunction Predicts Long-Term Outcome in Simultaneous Pancreas-Kidney Transplantation. Transplant Proc 2016;48:344–8.
Raine AEG, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992; 2: 7-35
Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-890
Harnett JD, Parfrey PS. Cardiac disease in uremia. Semin
Nephrol 1994; 14: 245-52 4. Fliser D, Schweizer C, Ritz E. How many patients with renal insufficiency survive until endstage renal failure? [letter]. Nephrol Dial Transplant 1991; 6: 600
Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardio graphic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192
Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey PS. The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 1993; 65: 212-214
Prisant LM, Kleinman DJ, Carr AA. Assessment of echocardio graphic left ventricular mass before and after acute volume depletion. Am J Hypertension 1994; 7: 425-428 8. London GM, Fabiani F, Marchais SJ et al. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int1987; 31: 973-980 9.
Silberberg JS, Barre PE, Prichard SS, Sniderman SD. Impact of left ventricular hypertrophy on survival in end-stage renal dis ease. Kidney Int 1989; 36: 286-290
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PK. The prognostic importance of left ventricular geo metry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024 2031
London GM, Fabiani F. Left ventricular dysfunction in end stage renal disease: echocardiographic insights. In: Parfrey PS, Harnett JD, eds Cardiac dysfunction in chronic uremia. Kluwer Academic Publishers: Boston 1992; 117-137
Zehnder C, Zuber M, Sulzer M et al. Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients. Nephron 1992; 61: 21-25
Harnett JD, Kent GM, Foley RN, Parfrey PS. Cardiac function and hematocrit level. Am J Kidney Dis 1995; 25 [Suppl 1]: S3-S7 14. Rodby RA, Vonesh EF, Korbet SMK. Blood pressures in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring. Am J Kidney Dis 1994; 23: 401-411
Cheigh JS, Milite C, Sullivan IF, Rubin AL, Stenzel KH. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992; 19: 453-459 Verdecchia P, Schillaci G, Guerrieri M et al. Circadian blood.pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536
Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe DN. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 1994; 24: 768-776
Huting J, Kramer W, Schutterle G, Wizemann V. Analysis of left-ventricular changes associated with chronic hemodialysis. Nephron 1988; 49: 284-290
Charra B. Control of blood pressure in long slow hemodialysis. Blood Purification 1994; 12: 252-258
Morita S, Asou T, Kuboyama I, Tokunaga K, Harasawa Y, Sunagawa K. Increased characteristic impedance causes left ventricular hypertrophy in dogs. Circulation 1989; II: 299
Cannella G, Paoletti E, Delfino R, Peloso G, Molinari S, Battista-Traverso G. Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993; 44: 881-886.
Roithinger FX, Punzengruber C, Wallner M et al. The influence of ACE-inhibition on myocardial mass and diastolic function in chronic hemodialysis patients with adequate control of blood pressure. Clin Nephrol 1994; 42: 309-314
Neff MS, Eiser AR, Slifkin RF et al. Patients surviving 10 years of hemodialysis. Am J Med 1983; 74: 996-1004
Leunissen KM, Kouw P, Kooman JP et al. New techniques to determine fluid status in hemodialyzed patients. Kidney Int 1993; 41 [Suppl]: S50-S56
Amann K, Neususs R. Ritz E, Irzyniec T, Wiest G, Mall G. Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertension 1995; 8: 409-417
Amann K, Tornig J, Flechtenmacher C, Nabokov A, Mall G, Ritz E. Blood-pressure independent wall thickening of intramyocardial arterioles in experimental uremia: evidence for a permissive action of PTH. Nephrol Dial Transplant 1995; 10: 2043 2048
Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G. Reduced capillary density in the myocardium of uremic rats a stereological study. Kidney Int 1992; 42: 1079-1085
Tornig J, Amann K, Nichols C, Zeier M, Mall G, Ritz E. Differential effects of antihypertensive treatment on abnormal cardiac structure in experimental uremia. J Am Soc Nephrol 1994; 5: 796
Himelman RB, Landzberg JS, Simonson JS et al. Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 1988; 12: 915-923
Wizemann V, Blank S, Kramer W. Diastolic dysfunction of the left ventricle in dialysis patients. Contrib Nephrol 1994; 106: 106-109
Kooman JP, Wijnen JA, Draaijer P et al. Compliance and reactivity of the peripheral venous system in chronic intermittent hemodialysis. Kidney Int 1992; 41: 1041-1048
Fujimoto S, Kagoshima T, Hashimoto T, Nakajima T, Dohi K. Left ventricular diastolic function in patients on maintenance hemodialysis: comparison with hypertensive heart disease and hypertrophic cardiomyopathy. Clin Nephrol 1994; 42: 109-116
Ruffmann K, Mandelbaum A, Bommer J, Schmidli M, Ritz E. Doppler echocardiographic findings in dialysis patients. Nephrol Dial Transplant 1990; 5: 426-431
Ritz E, Koch M. Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993; 21: 113-118
Parfrey PS, Harnett ID, Foley RN et al. Impact of renal transplantation on uremic cardiomyopathy. Transplantation 1995; 60: 908-914
Amann K, Ritz E. Cardiac structure and function in renal disease. Sémin Pitié 1996: 41-47.
